Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting
pharmaceutical investing Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
pharmaceutical investing Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
medical device investing Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
RecycLiCo’s U.S. Subsidiary and Alaska Energy Metals Corporation Enter Memorandum of Understanding to Advance Goal of Creating Domestic Critical Metal Supply Chain
